Phase I trial of a sequence-specific combination of the HDAC inhibitor, vorinostat (SAHA) followed by doxorubicin in advanced solid tumor malignancies

被引：0
|
作者：
Daud, A.
Schmitt, M.
Marchion, D.
Bicaku, E.
Minton, S.
Egorin, M.
Zwiebel, J.
Chiappori, A.
Sullivan, D.
Munster, P.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3502
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors
    Deming, Dustin A.
    Ninan, Jacob
    Bailey, Howard H.
    Kolesar, Jill M.
    Eickhoff, Jens
    Reid, Joel M.
    Ames, Matthew M.
    McGovern, Renee M.
    Alberti, Dona
    Marnocha, Rebecca
    Espinoza-Delgado, Igor
    Wright, John
    Wilding, George
    Schelman, William R.
    [J]. INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 323 - 329
  • [42] Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies
    Hubbard, Joleen M.
    Yin, Jun
    Schenk, Erin L.
    Qin, Rui
    Reid, Joel M.
    Strand, Carrie
    Fiskum, Jack
    Menefee, Michael
    Lin, Grace
    Doyle, L. Austin
    Ivy, Percy
    Erlichman, Charles
    Adjei, Alex
    Haluska, Paul
    Costello, Brian A.
    [J]. INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 115 - 123
  • [43] Phase I trial of BMS-247550 and gemcitabine in patients with advanced solid tumor malignancies.
    Anderson, S
    Dizon, D
    Sabbatini, P
    Dupont, J
    Pezzulli, S
    Massey, A
    Aghajanian, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 151S - 151S
  • [44] A phase I trial of the mTOR inhibitor temsirolimus (TEM) in combination with capecitabine (CAP) in patients with advanced malignancies.
    Pishvaian, Michael J.
    Wang, Hongkun
    Hardesty, Rosemarie A.
    Deeken, John F.
    He, Aiwu Ruth
    Subramaniam, Deepa Suresh
    Zhuang, Tingting
    McCarthy, Damian L.
    Melville, Heather
    Albanese, Christopher
    Marshall, John
    Hwang, Jimmy J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
    Munster, P. N.
    Marchion, D.
    Thomas, S.
    Egorin, M.
    Minton, S.
    Springett, G.
    Lee, J-H
    Simon, G.
    Chiappori, A.
    Sullivan, D.
    Daud, A.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (07) : 1044 - 1050
  • [46] A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors
    Dustin A. Deming
    Jacob Ninan
    Howard H. Bailey
    Jill M. Kolesar
    Jens Eickhoff
    Joel M. Reid
    Matthew M. Ames
    Renee M. McGovern
    Dona Alberti
    Rebecca Marnocha
    Igor Espinoza-Delgado
    John Wright
    George Wilding
    William R. Schelman
    [J]. Investigational New Drugs, 2014, 32 : 323 - 329
  • [47] Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
    P N Munster
    D Marchion
    S Thomas
    M Egorin
    S Minton
    G Springett
    J-H Lee
    G Simon
    A Chiappori
    D Sullivan
    A Daud
    [J]. British Journal of Cancer, 2009, 101 : 1044 - 1050
  • [48] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    Schelman, William R.
    Morgan-Meadows, Sherry
    Marnocha, Rebecca
    Lee, Fred
    Eickhoff, Jens
    Huang, Wei
    Pomplun, Marcia
    Jiang, Zhisheng
    Alberti, Dona
    Kolesar, Jill M.
    Ivy, Percy
    Wilding, George
    Traynor, Anne M.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1147 - 1156
  • [49] Bortezomib and pegylated liposomal doxorubicin: phase I trial in patients with advanced hematologic malignancies
    [J]. Nature Clinical Practice Oncology, 2005, 2 (6): : 278 - 279
  • [50] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    William R. Schelman
    Sherry Morgan-Meadows
    Rebecca Marnocha
    Fred Lee
    Jens Eickhoff
    Wei Huang
    Marcia Pomplun
    Zhisheng Jiang
    Dona Alberti
    Jill M. Kolesar
    Percy Ivy
    George Wilding
    Anne M. Traynor
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 63 : 1147 - 1156
12345